Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
61.4M
-
Shares change
-
-1.72M
-
Total reported value, excl. options
-
$43M
-
Value change
-
-$1.25M
-
Put/Call ratio
-
0.51
-
Number of buys
-
21
-
Number of sells
-
-28
-
Price
-
$0.70
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q1 2025
80 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q1 2025.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 61.4M shares
of 170M outstanding shares and own 36.01% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (23.1M shares), FMR LLC (21.9M shares), VANGUARD GROUP INC (6.09M shares), BlackRock, Inc. (1.76M shares), GEODE CAPITAL MANAGEMENT, LLC (1.62M shares), UBS Group AG (1.46M shares), Vontobel Holding Ltd. (1.09M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (834K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (717K shares), and STATE STREET CORP (501K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.